Home ETF List About

Portfolio Holdings Detail for ISIN IE0003WV2ME7
Stock Name / FundiShares S&P 500 Equal Weight UCITS ETF GBP Hedged (Acc)
IssuerBlackrock
Entity holding fund iShares III Public Limited Company
Entity Type
Entity LEI 549300PZLRJB7M8H1057
ETF TickerISPE(GBP) LSE
ETF TickerISPE.L(GBP) LSE

Holdings detail for TECH

Stock NameBio-Techne Corp
TickerTECH(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS09073M1045
LEI54930073RLKQ51TILZ35

Show aggregate TECH holdings

News associated with TECH

Royal Bank Of Canada Upgrades Bio-Techne (NASDAQ:TECH) to “Moderate Buy”
Bio-Techne (NASDAQ:TECH – Get Free Report) was upgraded by equities research analysts at Royal Bank Of Canada from a “hold” rating to a “moderate buy” rating in a research note issued on Wednesday,Zacks.com reports. Several other analysts have also recently issued reports on TECH. UBS Group lowered their target price on shares of Bio-Techne from […] - 2025-09-05 05:36:53
Bio-Techne Corp (NASDAQ:TECH) Shares Acquired by Charles Schwab Investment Management Inc.
Charles Schwab Investment Management Inc. lifted its stake in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 3.1% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,511,260 shares of the biotechnology company’s stock after buying an additional 45,570 shares during the quarter. […] - 2025-08-13 05:12:55
How The Pieces Add Up: TCAF Headed For $40
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-07-29 10:39:29
Bio-Techne Corp (NASDAQ:TECH) Shares Sold by Cwm LLC
Cwm LLC cut its position in Bio-Techne Corp (NASDAQ:TECH – Free Report) by 6.2% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,927 shares of the biotechnology company’s stock after selling 786 shares during the quarter. Cwm LLC’s holdings in Bio-Techne […] - 2025-07-24 04:47:00
Bio-Techne Corp (NASDAQ:TECH) Shares Sold by Signaturefd LLC
Signaturefd LLC decreased its holdings in Bio-Techne Corp (NASDAQ:TECH – Free Report) by 9.8% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,690 shares of the biotechnology company’s stock after selling 293 shares during the quarter. Signaturefd LLC’s holdings in Bio-Techne were […] - 2025-07-21 05:43:00
Mutual of America Capital Management LLC Has $3.25 Million Stock Holdings in Bio-Techne Corp (NASDAQ:TECH)
Mutual of America Capital Management LLC raised its holdings in Bio-Techne Corp (NASDAQ:TECH – Free Report) by 29.8% in the 1st quarter, HoldingsChannel reports. The fund owned 55,493 shares of the biotechnology company’s stock after acquiring an additional 12,740 shares during the period. Mutual of America Capital Management LLC’s holdings in Bio-Techne were worth $3,254,000 […] - 2025-07-18 05:16:49
Bio-Techne Corp (NASDAQ:TECH) Shares Bought by Xponance Inc.
Xponance Inc. increased its holdings in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 3.0% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 21,540 shares of the biotechnology company’s stock after purchasing an additional 619 shares during the period. Xponance […] - 2025-07-16 06:24:53
Cerity Partners LLC Grows Position in Bio-Techne Corp (NASDAQ:TECH)
Cerity Partners LLC raised its position in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 20.1% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 132,742 shares of the biotechnology company’s stock after purchasing an additional 22,259 shares during the quarter. Cerity Partners LLC’s holdings in Bio-Techne were worth $7,783,000 at the end […] - 2025-07-16 05:38:08
DekaBank Deutsche Girozentrale Sells 261 Shares of Bio-Techne Corp (NASDAQ:TECH)
DekaBank Deutsche Girozentrale lowered its position in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 1.4% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 17,926 shares of the biotechnology company’s stock after selling 261 shares during the quarter. DekaBank Deutsche […] - 2025-07-14 05:34:48
Bio-Techne Corp (NASDAQ:TECH) Shares Sold by Vontobel Holding Ltd.
Vontobel Holding Ltd. lessened its holdings in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 5.1% during the first quarter, HoldingsChannel reports. The fund owned 4,960 shares of the biotechnology company’s stock after selling 269 shares during the period. Vontobel Holding Ltd.’s holdings in Bio-Techne were worth $291,000 at the end of the most […] - 2025-07-09 05:02:49
GAMMA Investing LLC Lowers Stake in Bio-Techne Corp (NASDAQ:TECH)
GAMMA Investing LLC reduced its stake in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 38.0% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,795 shares of the biotechnology company’s stock after selling 1,101 shares during the quarter. GAMMA Investing LLC’s holdings in […] - 2025-07-07 04:17:11
Bio-Techne Corp (NASDAQ:TECH) Shares Purchased by Janney Montgomery Scott LLC
Janney Montgomery Scott LLC raised its position in Bio-Techne Corp (NASDAQ:TECH – Free Report) by 4.6% during the 1st quarter, Holdings Channel reports. The firm owned 11,210 shares of the biotechnology company’s stock after acquiring an additional 490 shares during the quarter. Janney Montgomery Scott LLC’s holdings in Bio-Techne were worth $657,000 at the end […] - 2025-07-02 05:43:07
Bio-Techne Corp (NASDAQ:TECH) Shares Purchased by Diversified Trust Co
Diversified Trust Co grew its holdings in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 10.0% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 13,824 shares of the biotechnology company’s stock after buying an additional 1,260 shares during the quarter. […] - 2025-06-30 05:10:55
Bessemer Group Inc. Sells 61,323 Shares of Bio-Techne Corp (NASDAQ:TECH)
Bessemer Group Inc. decreased its holdings in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 75.6% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 19,748 shares of the biotechnology company’s stock after selling 61,323 shares during the quarter. Bessemer […] - 2025-06-30 04:38:49
Chevy Chase Trust Holdings LLC Sells 2,582 Shares of Bio-Techne Corp (NASDAQ:TECH)
Chevy Chase Trust Holdings LLC cut its position in Bio-Techne Corp (NASDAQ:TECH – Free Report) by 3.0% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 82,909 shares of the biotechnology company’s stock after selling 2,582 shares during the quarter. Chevy Chase Trust […] - 2025-06-27 05:12:48
Retirement Systems of Alabama Sells 430 Shares of Bio-Techne Corp (NASDAQ:TECH)
Retirement Systems of Alabama lessened its stake in Bio-Techne Corp (NASDAQ:TECH – Free Report) by 1.2% in the first quarter, HoldingsChannel reports. The firm owned 33,972 shares of the biotechnology company’s stock after selling 430 shares during the period. Retirement Systems of Alabama’s holdings in Bio-Techne were worth $1,992,000 at the end of the most […] - 2025-06-26 06:06:47
Bio-Techne Corp (NASDAQ:TECH) Shares Acquired by Oppenheimer Asset Management Inc.
Oppenheimer Asset Management Inc. increased its holdings in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 4.6% in the first quarter, Holdings Channel reports. The firm owned 67,166 shares of the biotechnology company’s stock after acquiring an additional 2,929 shares during the period. Oppenheimer Asset Management Inc.’s holdings in Bio-Techne were worth $3,938,000 at […] - 2025-06-26 05:16:55
Bio-Techne Corp (NASDAQ:TECH) Shares Bought by Exchange Traded Concepts LLC
Exchange Traded Concepts LLC lifted its stake in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 21.2% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,803 shares of the biotechnology company’s stock after buying an additional 490 shares during the quarter. Exchange […] - 2025-06-24 04:36:51
CX Institutional Invests $27,000 in Bio-Techne Corp (NASDAQ:TECH)
CX Institutional acquired a new position in Bio-Techne Corp (NASDAQ:TECH – Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 459 shares of the biotechnology company’s stock, valued at approximately $27,000. Several other large investors also […] - 2025-06-19 04:52:57
Bio-Techne Corp (NASDAQ:TECH) Receives Consensus Rating of “Hold” from Brokerages
Bio-Techne Corp (NASDAQ:TECH – Get Free Report) has earned an average recommendation of “Hold” from the eleven analysts that are presently covering the firm, MarketBeat reports. Six equities research analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 1-year price objective among analysts […] - 2025-06-18 06:12:46
Mn Services Vermogensbeheer B.V. Sells 6,200 Shares of Bio-Techne Corp (NASDAQ:TECH)
Mn Services Vermogensbeheer B.V. trimmed its holdings in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 9.9% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 56,200 shares of the biotechnology company’s stock after selling 6,200 shares during the quarter. Mn Services […] - 2025-06-18 05:32:53
Bio-Techne (NASDAQ:TECH) Cut to Hold at Wall Street Zen
Wall Street Zen lowered shares of Bio-Techne (NASDAQ:TECH – Free Report) from a buy rating to a hold rating in a research note issued to investors on Sunday. Several other analysts have also commented on the stock. Citigroup lowered their price target on shares of Bio-Techne from $80.00 to $70.00 and set a “neutral” rating […] - 2025-06-09 03:44:45
Rhumbline Advisers Increases Position in Bio-Techne Co. (NASDAQ:TECH)
Rhumbline Advisers lifted its holdings in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 15.1% during the first quarter, Holdings Channel.com reports. The institutional investor owned 300,474 shares of the biotechnology company’s stock after acquiring an additional 39,345 shares during the quarter. Rhumbline Advisers’ holdings in Bio-Techne were worth $17,617,000 as of its most recent filing […] - 2025-06-08 05:35:05
Squarepoint Ops LLC Buys 4,816 Shares of Bio-Techne Co. (NASDAQ:TECH)
Squarepoint Ops LLC boosted its stake in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 113.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 9,060 shares of the biotechnology company’s stock after buying an additional 4,816 shares during […] - 2025-06-03 05:06:58
Universal Beteiligungs und Servicegesellschaft mbH Invests $4.08 Million in Bio-Techne Co. (NASDAQ:TECH)
Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in Bio-Techne Co. (NASDAQ:TECH – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 56,666 shares of the biotechnology company’s stock, valued at approximately $4,082,000. Other hedge funds and other institutional investors […] - 2025-06-02 05:36:54
Bio-Techne Co. (NASDAQ:TECH) Shares Sold by Two Sigma Advisers LP
Two Sigma Advisers LP trimmed its stake in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 4.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 17,900 shares of the biotechnology company’s stock after selling 900 shares during the quarter. Two Sigma Advisers […] - 2025-06-01 05:44:50
How The Parts Add Up: XLV Headed For $158
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-26 08:22:41
Cetera Investment Advisers Decreases Position in Bio-Techne Co. (NASDAQ:TECH)
Cetera Investment Advisers lessened its holdings in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 4.3% during the fourth quarter, Holdings Channel.com reports. The firm owned 19,857 shares of the biotechnology company’s stock after selling 887 shares during the quarter. Cetera Investment Advisers’ holdings in Bio-Techne were worth $1,430,000 at the end of the most recent […] - 2025-05-22 04:52:55
Bank of America Corp DE Sells 303,523 Shares of Bio-Techne Co. (NASDAQ:TECH)
Bank of America Corp DE cut its holdings in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 37.0% during the 4th quarter, Holdings Channel reports. The fund owned 516,549 shares of the biotechnology company’s stock after selling 303,523 shares during the period. Bank of America Corp DE’s holdings in Bio-Techne were worth $37,207,000 as of its […] - 2025-05-16 05:31:04
Mercer Global Advisors Inc. ADV Reduces Stake in Bio-Techne Co. (NASDAQ:TECH)
Mercer Global Advisors Inc. ADV decreased its stake in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 15.7% during the fourth quarter, HoldingsChannel.com reports. The firm owned 4,028 shares of the biotechnology company’s stock after selling 751 shares during the period. Mercer Global Advisors Inc. ADV’s holdings in Bio-Techne were worth $290,000 at the […] - 2025-05-16 04:49:06

iShares S&P 500 Equal Weight UCITS ETF GBP Hedged (Acc) TECH holdings

DateNumber of TECH Shares HeldBase Market Value of TECH SharesLocal Market Value of TECH SharesChange in TECH Shares HeldChange in TECH Base ValueCurrent Price per TECH Share HeldPrevious Price per TECH Share Held
2025-09-18 (Thursday)169,074TECH holding increased by 202USD 8,959,231TECH holding increased by 258946USD 8,959,231202USD 258,946 USD 52.99 USD 51.52
2025-09-17 (Wednesday)168,872USD 8,700,285TECH holding decreased by -43907USD 8,700,2850USD -43,907 USD 51.52 USD 51.78
2025-09-16 (Tuesday)168,872USD 8,744,192TECH holding increased by 27019USD 8,744,1920USD 27,019 USD 51.78 USD 51.62
2025-09-15 (Monday)168,872USD 8,717,173USD 8,717,173
2025-09-12 (Friday)168,872USD 8,656,379USD 8,656,379
2025-09-10 (Wednesday)168,872USD 8,605,717USD 8,605,717
2025-09-09 (Tuesday)168,972USD 9,158,282USD 9,158,282
2025-09-08 (Monday)168,972USD 9,143,075USD 9,143,075
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of TECH by Blackrock for IE0003WV2ME7

Show aggregate share trades of TECH

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-09-18BUY202 52.990* 61.60
2025-08-18BUY184 53.290* 61.74
2025-08-12SELL-100 52.830* 61.91 Profit of 6,191 on sale
2025-07-29BUY106 57.870* 62.00
2025-07-23SELL-300 55.310* 62.07 Profit of 18,621 on sale
2025-07-22SELL-600 53.120* 62.12 Profit of 37,273 on sale
2025-07-21SELL-200 50.270* 62.19 Profit of 12,437 on sale
2025-07-15SELL-200 51.420* 62.31 Profit of 12,461 on sale
2025-07-14SELL-500 52.620* 62.36 Profit of 31,180 on sale
2025-07-11SELL-300 54.140* 62.41 Profit of 18,722 on sale
2025-07-10SELL-1,200 54.410* 62.45 Profit of 74,943 on sale
2025-07-09SELL-400 52.590* 62.51 Profit of 25,004 on sale
2025-07-08SELL-1,300 52.680* 62.57 Profit of 81,336 on sale
2025-07-03SELL-1,700 53.140* 62.74 Profit of 106,661 on sale
2025-07-02SELL-308 53.180* 62.80 Profit of 19,342 on sale
2025-06-27SELL-4,900 51.840* 62.93 Profit of 308,368 on sale
2025-06-25BUY100 51.890* 63.06
2025-06-24SELL-3,700 50.000* 63.14 Profit of 233,619 on sale
2025-06-23SELL-100 49.300* 63.23 Profit of 6,323 on sale
2025-06-20BUY36,877 49.890* 63.31
2025-06-18SELL-486 50.130* 63.47 Profit of 30,847 on sale
2025-06-17SELL-891 49.500* 63.56 Profit of 56,632 on sale
2025-06-11SELL-243 51.540* 63.71 Profit of 15,482 on sale
2025-06-10SELL-567 51.400* 63.79 Profit of 36,170 on sale
2025-06-06SELL-162 48.690* 63.98 Profit of 10,365 on sale
2025-06-05SELL-1,377 48.310* 64.08 Profit of 88,242 on sale
2025-06-02SELL-6,561 48.610* 64.38 Profit of 422,417 on sale
2025-05-30SELL-1,458 48.400* 64.49 Profit of 94,027 on sale
2025-05-29SELL-162 48.330* 64.60 Profit of 10,465 on sale
2025-05-27SELL-162 48.690* 64.82 Profit of 10,501 on sale
2025-05-23SELL-243 46.780* 65.07 Profit of 15,813 on sale
2025-05-16SELL-1,215 49.150* 65.67 Profit of 79,793 on sale
2025-05-15SELL-243 48.240* 65.80 Profit of 15,989 on sale
2025-05-13SELL-81 51.610* 66.04 Profit of 5,349 on sale
2025-05-12SELL-567 53.900* 66.13 Profit of 37,493 on sale
2025-05-09SELL-486 49.940* 66.25 Profit of 32,196 on sale
2025-05-08SELL-2,349 49.780* 66.37 Profit of 155,904 on sale
2025-05-07SELL-162 48.750* 66.50 Profit of 10,774 on sale
2025-05-06BUY40 47.720* 66.65
2025-05-01BUY3,078 49.630* 67.04
2025-04-30BUY1,701 50.350* 67.17
2025-04-29SELL-324 50.500* 67.30 Profit of 21,806 on sale
2025-04-28SELL-400 50.250* 67.44 Profit of 26,975 on sale
2025-04-25BUY162 50.240* 67.58
2025-04-24SELL-81 50.780* 67.71 Profit of 5,485 on sale
2025-04-22SELL-10,854 49.080* 68.01 Profit of 738,208 on sale
2025-04-17SELL-4,941 48.100* 68.52 Profit of 338,576 on sale
2025-04-16BUY162 49.975* 68.68
2025-04-15BUY162 51.070* 68.83
2025-04-10SELL-5,103 49.260* 69.31 Profit of 353,699 on sale
2025-04-09BUY405 54.070* 69.45
2025-04-08BUY81 48.810* 69.63
2025-04-07BUY1,440 52.310* 69.79
2025-04-04BUY880 51.720* 69.96
2025-04-02BUY560 58.380* 70.06
2025-04-01BUY6,398 57.350* 70.18
2025-03-31BUY243 58.630* 70.29
2025-03-25BUY81 59.980* 70.72
2025-03-21BUY25,613 60.610* 70.91
2025-03-20BUY138 60.340* 71.02
2025-03-18BUY345 62.830* 71.21
2025-03-17BUY44 62.580* 71.30
2025-03-14SELL-25 62.160* 71.39 Profit of 1,785 on sale
2025-03-13SELL-4,465 59.880* 71.52 Profit of 319,322 on sale
2025-03-12BUY828 60.235* 71.64
2025-03-11BUY828 58.470* 71.78
2025-03-07BUY276 64.370* 71.96
2025-03-06BUY966 63.390* 72.06
2025-03-05BUY5,244 62.200* 72.17
2025-03-04BUY276 60.120* 72.31
2025-03-03BUY345 61.190* 72.44
2025-02-28BUY4,783 61.750* 72.56
2025-02-27BUY603 61.230* 72.70
2025-02-26SELL-350 64.150* 72.80 Profit of 25,481 on sale
2025-02-25SELL-67 64.220* 72.91 Profit of 4,885 on sale
2025-02-24BUY68 65.560* 73.00
2025-02-20SELL-871 65.490* 73.19 Profit of 63,753 on sale
2025-02-19BUY268 65.800* 73.29
2025-02-18BUY274 65.290* 73.39
2025-02-13BUY7,638 66.770* 73.68
2025-02-12BUY2,278 67.440* 73.77
2025-02-11BUY1,881 68.340* 73.85
2025-02-07BUY201 72.810* 73.92
2025-02-06BUY2,680 75.010* 73.90
2025-02-05BUY1,340 75.250* 73.88
2025-02-04BUY1,005 72.550* 73.90
2025-02-03SELL-5,829 72.050* 73.93 Profit of 430,929 on sale
2025-01-31BUY536 73.550* 73.93
2025-01-30BUY67 72.760* 73.95
2025-01-29BUY1,139 71.830* 73.99
2025-01-28BUY402 74.600* 73.98
2025-01-27BUY402 76.450* 73.94
2025-01-24BUY402 77.050* 73.88
2025-01-23BUY1,139 76.910* 73.83
2025-01-22BUY670 78.710* 73.75
2025-01-21BUY3,953 78.750* 73.66
2025-01-17BUY804 75.830* 73.58
2025-01-15BUY402 75.130* 73.51
2025-01-13BUY1,139 76.420* 73.42
2025-01-10BUY870 73.310* 73.43
2024-12-31BUY201 72.030* 73.42
2024-12-30BUY268 72.290* 73.45
2024-12-27BUY1,301 72.980* 73.46
2024-12-23BUY402 72.740* 73.49
2024-12-20BUY1,351 73.170* 73.50
2024-12-19BUY804 71.390* 73.55
2024-12-17BUY611 75.270* 73.57
2024-12-16BUY201 76.160* 73.49
2024-12-13BUY335 75.690* 73.43
2024-12-11BUY201 76.810* 73.33
2024-12-10BUY134 77.120* 73.22
2024-12-09BUY134 77.400* 73.09
2024-12-05SELL-402 73.890* 73.01 Profit of 29,351 on sale
2024-12-04BUY68 75.890* 72.91
2024-12-02BUY268 76.020* 72.72
2024-11-29BUY1,188 75.360* 72.62
2024-11-27BUY264 75.380* 72.39
2024-11-26BUY660 74.870* 72.28
2024-11-25BUY8,184 74.390* 72.18
2024-11-22BUY198 71.280* 72.23
2024-11-21BUY198 71.050* 72.28
2024-11-20BUY858 68.720* 72.47
2024-11-19SELL-858 66.370* 72.81 Profit of 62,471 on sale
2024-11-18BUY3,960 66.860* 73.16
2024-11-12BUY792 74.410* 73.08
2024-11-11BUY198 74.690* 72.98
2024-11-08BUY796 75.960* 72.76
2024-11-07BUY1,344 76.420* 72.48
2024-11-06BUY594 75.830* 72.20
2024-11-05BUY132 77.620* 71.71
2024-11-04BUY685 75.900* 71.29
2024-11-01BUY330 75.310* 70.84
2024-10-30BUY198 76.020* 69.69
2024-10-29BUY1,254 70.740* 69.51
2024-10-25BUY264 68.680* 69.50
2024-10-24BUY198 68.370* 69.88
2024-10-22BUY396 69.950* 70.36
2024-10-21BUY330 70.360* 0.00
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of TECH

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19651,35111,081870,85674.8%
2025-09-18364,7260635,89757.4%
2025-09-17271,704109711,34538.2%
2025-09-16359,43201,639,77821.9%
2025-09-15279,70130759,61936.8%
2025-09-12389,4061,558859,94245.3%
2025-09-11291,39729720,35140.5%
2025-09-10623,442211,428,22043.7%
2025-09-09496,5733171,091,06945.5%
2025-09-08324,673215797,10140.7%
2025-09-05300,894351736,45040.9%
2025-09-04298,14550849,32735.1%
2025-09-03396,4460721,67254.9%
2025-09-02157,8040635,17724.8%
2025-08-29267,6043,210620,56843.1%
2025-08-28552,63101,621,66434.1%
2025-08-27319,849448770,75941.5%
2025-08-26501,622768647,13777.5%
2025-08-25403,253775980,20941.1%
2025-08-22345,299759513,18267.3%
2025-08-21321,8404618,18452.1%
2025-08-20340,4275602,03456.5%
2025-08-19355,2340523,53767.9%
2025-08-18257,2510489,73252.5%
2025-08-15172,7352321,97653.6%
2025-08-14267,327265566,98647.1%
2025-08-13301,96036655,81446.0%
2025-08-12336,42393800,31842.0%
2025-08-11335,295637799,43341.9%
2025-08-08425,18121,371853,69549.8%
2025-08-07562,06246,8941,314,23842.8%
2025-08-061,493,78312,2823,400,01843.9%
2025-08-05325,3055,603950,69834.2%
2025-08-04295,3211,870616,19947.9%
2025-08-01382,01610,466684,12755.8%
2025-07-31403,7771,690959,80042.1%
2025-07-30313,8576,379528,86459.3%
2025-07-29438,3262,402761,35057.6%
2025-07-28682,9256,9001,041,30065.6%
2025-07-25615,59726,3711,044,88258.9%
2025-07-241,073,71263,0372,073,18551.8%
2025-07-23529,3193,7241,012,04152.3%
2025-07-22346,5822,688608,36257.0%
2025-07-21871,04541,362,95163.9%
2025-07-18384,0621,700787,47848.8%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.